Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494449/ |